2026 RNDS | Day Three Kickoff: “Research That Changes Lives” @wearesrna
2026 RNDS | Day Three Kickoff: “Research That Changes Lives”  @wearesrna
Uploaded October 2026 | Updated November 2026, 2 hours ago
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Michael Levy, MD, PhD, of Massachusetts General Hospital opened day three, "Research that changes lives," as the morning host [00:00:05]. He introduced himself as someone who trained with Dr. Pardo and Dr. Greenberg at Johns Hopkins and who now researches MOG antibody disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), and transverse myelitis (TM) [00:00:20]. He ran a quick audience survey about where people would travel after RNDS [00:00:39]. He then previewed the research areas for the day: epidemiology and genetics, what triggers attacks and which parts of the immune system are involved, MRI, blood tests, and treatments and clinical trials [00:02:35]. He closed by walking through the agenda for the morning and afternoon and reminding everyone that the sessions were being recorded [00:03:44].

Michael Levy, MD, PhD, is an Associate Neurologist at Massachusetts General Hospital and Research Director of the Division of Neuroimmunology and Neuroinfectious Disease. He completed the MD/PhD program at Baylor College of Medicine with a focus on neuroscience. He then completed his internship, neurology residency, and a fellowship in neuroimmunology at Johns Hopkins. In 2009, Dr. Levy joined the Johns Hopkins faculty as Assistant Professor, where he started the Neuromyelitis Optica Clinic and Research Laboratory. In 2019, he moved to Massachusetts General Hospital and Harvard Medical School to develop the research program in neuroimmunology.

00:00 Welcome to Day Three
00:20 Dr. Levy's Background
00:39 Audience Survey
02:35 Research Areas for Today
03:16 Imaging and Blood Tests
03:44 Morning Agenda
04:07 Lunch, Afternoon Sessions, and Closing
2026 RNDS | Day Three Kickoff: “Research That Changes Lives”2024 RNDS | Rehabilitation StrategiesAsk the Expert 1407. Open Q&A on Acute Disseminated Encephalomyelitis (ADEM)2025 RNDS | New and Emerging Therapeutics2023 RNDS en Español | ¿Qué es MOGAD y EMAD?1115. A Conversation about Grief and Loss with Chris Lopardi201. Dr. Cristina Sadowsky1303. Parenting is Hard | Part 12025 RNDS | Tips and tricks to obtain access to care; Transition from pediatric to adult care1213. Operant Conditioning Rehabilitation Studies1305. FES 101SRNA | The Power of Community
SRNA |

2026 RNDS | Day Three Kickoff: “Research That Changes Lives”

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER